These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8856029)

  • 41. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
    Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of recombinant VP3 protein of infectious bursal disease virus in three different expression systems, antigenic analysis of the obtained polypeptides and development of an ELISA test.
    Shirokov DA; Manuvera VA; Miroshina OA; Dubovoi AS; Samuseva GN; Dmitrieva ME; Lazarev VN
    Arch Virol; 2020 Jul; 165(7):1611-1620. PubMed ID: 32405826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.
    Zhao M; Li XJ; Tang ZM; Yang F; Wang SL; Cai W; Zhang K; Xia NS; Zheng ZZ
    J Biol Chem; 2015 Aug; 290(32):19910-22. PubMed ID: 26085097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
    Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
    J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly.
    Castón JR; Martínez-Torrecuadrada JL; Maraver A; Lombardo E; Rodríguez JF; Casal JI; Carrascosa JL
    J Virol; 2001 Nov; 75(22):10815-28. PubMed ID: 11602723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and characterization of a novel B-cell epitope on Aleutian Mink Disease virus capsid protein VP2 using a monoclonal antibody.
    Lu T; Wang Y; Ge J; Ma Q; Yan W; Zhang Y; Zhao L; Chen H
    Virus Res; 2018 Mar; 248():74-79. PubMed ID: 29278728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mapping of linear epitopes on the capsid proteins of swine vesicular disease virus using monoclonal antibodies.
    Borrego B; García-Ranea JA; Douglas A; Brocchi E
    J Gen Virol; 2002 Jun; 83(Pt 6):1387-1395. PubMed ID: 12029154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of antigenic epitopes of monoclonal antibodies against the VP2 protein of the 25 serotype of bluetongue virus.
    Xie S; Shi Y; Gong R; Cui W; Jiang Y; Liu M; Wang L; Zhou H; Qiao X; Li Y; Xu Y; Tang L
    Vet Microbiol; 2018 Jun; 219():136-143. PubMed ID: 29778186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States.
    Snyder DB; Vakharia VN; Savage PK
    Arch Virol; 1992; 127(1-4):89-101. PubMed ID: 1333761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination against very virulent infectious bursal disease virus using recombinant T4 bacteriophage displaying viral protein VP2.
    Cao YC; Shi QC; Ma JY; Xie QM; Bi YZ
    Acta Biochim Biophys Sin (Shanghai); 2005 Oct; 37(10):657-64. PubMed ID: 16215632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus.
    Becht H; Müller H; Müller HK
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():631-40. PubMed ID: 2450966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins.
    Vakharia VN; Snyder DB; Lütticken D; Mengel-Whereat SA; Savage PK; Edwards GH; Goodwin MA
    Vaccine; 1994 Apr; 12(5):452-6. PubMed ID: 8023554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
    Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.
    Wang W; Song Y; Liu L; Zhang Y; Wang T; Zhang W; Li K; Qi X; Gao Y; Gao L; Liu C; Zhang Y; Wang Y; Pan Q; He G; Wang X; Cui H
    Microb Cell Fact; 2019 Jan; 18(1):21. PubMed ID: 30704494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chimaeric VP2 proteins from infectious bursal disease virus containing the N-terminal M2e of H9 subtype avian influenza virus induce neutralizing antibody responses to both viruses.
    Tang Y; Gong Y; Wang Y; Wu P; Liu Y; Lu J; Gao F; Chen T; Hou F; Hou J
    Avian Pathol; 2013; 42(3):260-7. PubMed ID: 23607544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping of epitopes of VP2 protein of chicken anemia virus using monoclonal antibodies.
    Wang X; Gao H; Gao Y; Fu C; Wang Z; Lu G; Cheng Y; Wang X
    J Virol Methods; 2007 Aug; 143(2):194-9. PubMed ID: 17481740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of three PPV1 VP2 protein-specific B cell linear epitopes using monoclonal antibodies against baculovirus-expressed recombinant VP2 protein.
    Sun J; Huang L; Wei Y; Wang Y; Chen D; Du W; Wu H; Feng L; Liu C
    Appl Microbiol Biotechnol; 2015 Nov; 99(21):9025-36. PubMed ID: 26153140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of neutralizing epitopes among infectious bursal disease viruses using radioimmunoprecipitation.
    Whetzel PL; Jackwood DJ
    Avian Dis; 1995; 39(3):499-506. PubMed ID: 8561733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus.
    Martínez-Torrecuadrada JL; Casal JI
    Virology; 1995 Jul; 210(2):391-9. PubMed ID: 7542417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus.
    Bayliss CD; Peters RW; Cook JK; Reece RL; Howes K; Binns MM; Boursnell ME
    Arch Virol; 1991; 120(3-4):193-205. PubMed ID: 1659797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.